Primary Open Angle Glaucoma: Clinical Trials

10 trials for Primary Open Angle Glaucoma, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

10 completed. 10 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 410Completed 10

Follow Primary Open Angle Glaucoma: new trials by email Literature Review of Primary Open Angle Glaucoma trials Research Report on Primary Open Angle Glaucoma

Trials (filtered) newest first · largest first

All 10 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Tafluprost Preservative Free Switch Study
preservative free tafluprost 0.0015% - Glaucoma, Primary Open Angle Glaucoma
Phase 4CompletedTun Hussein Onn National Eye Hospital282019-02-012020-12-04
Evaluation of the XEN Implant in Moderate Primary Open Angle Glaucoma (POAG) Participants
XEN® Gel Stent, Cataract Surgery - Primary Open Angle Glaucoma
Phase 4CompletedAqueSys, Inc.1992013-12-052019-04-22
Safety and Efficacy Assessment of Monoprost® in Comparison With Lumigan® 0.01 % and Lumigan® 0.03% Unit Dose
Monoprost, Lumigan 0.01%, Lumigan 0.03% Unit Dose - Primary Open Angle Glaucoma, Ocular Hypertension
Phase 4CompletedLaboratoires Thea3792013-12-012020-04-02
An Open, Non-randomized Pilot Study on the Effect of Preservative Free Tafluprost (Saflutan® Augentropfen) in Patients With Ocular Hypertension or Primary Open Angle Glaucoma With an Uncontrolled Intraocular Pressure of 30 mmHg and More
Saflutan® 15 microgram/ml Augentropfen im Einzeldosisbehältnis - Primary Open Angle Glaucoma, Ocular Hypertension
Phase 4CompletedDr. Anton Hommer162013-10-012015-04-23
Laser-1st vs Drops-1st for Glaucoma and Ocular Hypertension
Primary Selective Laser Trabeculoplasty Treatment Pathway, Primary Medical Treatment Pathway - Primary Open Angle Glaucoma, Ocular Hypertension
Phase 4CompletedMoorfields Eye Hospital NHS Foundation Trust7182012-10-012018-01-10
Latanoprost Versus Tafluprost: 24-hour Intraocular Pressure (IOP)
Goldmann and Perkins applanation tonometry, TAFLUPROST 0.0015% EYEDROPS, LATANOPROST 0.005% EYEDROPS - Primary Open Angle Glaucoma, Ocular Hypertension
Phase 4CompletedAzienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia402011-03-012013-05-07
Efficacy And Safety of Pneumatic Trabeculoplasty
"model 1000 PNT vacuum controller" (the vacuum device for ocular suction) - Primary Open Angle Glaucoma
Phase 4CompletedUniversity of Catanzaro272009-06-012012-02-28
Study of the Intraocular Pressure (IOP)-Lowering Efficacy of Azopt 1.0% Compared to Timolol 0.5% in Patients With Glaucoma or Ocular Hypertension
brinzolamide 1.0% - Primary Open Angle Glaucoma, Ocular Hypertension
Phase 4CompletedAlcon Research302006-09-012016-11-18
24-Hour Intraocular Pressure (IOP) And Blood Pressure Control In Glaucoma And Ocular Hypertension Patients
timolol maleate 0.5%, latanoprost/timolol fixed combination, placebo (artificial tears) - Primary Open Angle Glaucoma, Ocular Hypertension
Phase 4CompletedAristotle University Of Thessaloniki302006-04-012014-05-12
Comparison of Brimonidine Purite, Dorzolamide, and Brinzolamide as Adjunctive Therapy to Prostaglandin Analogs
Brimonidine purite 0.15%, Dorzolamide 2%, Brinzolamide 1% - Primary Open Angle Glaucoma, Ocular Hypertension
Phase 4CompletedNorthwestern Ophthalmic Institute S.C.1202006-01-012008-05-08

Narrower conditions

Glaucoma, Open-Angle (10)  ·  Ocular Hypertension (8)  ·  Glaucoma (3)

Broader conditions

Eye Diseases (10)  ·  Glaucoma (7)  ·  Ocular Hypertension (2)

Interventions

Latanoprost (2)  ·  tafluprost (2)  ·  Bimatoprost (1)  ·  Cataract Extraction (1)  ·  Lubricant Eye Drops (1)  ·  Ophthalmic Solutions (1)  ·  brinzolamide (1)  ·  dorzolamide (1)

Sponsors

Alcon Research (1)  ·  AqueSys, Inc. (1)  ·  Aristotle University Of Thessaloniki (1)  ·  Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia (1)  ·  Dr. Anton Hommer (1)  ·  Laboratoires Thea (1)  ·  Moorfields Eye Hospital NHS Foundation Trust (1)  ·  Northwestern Ophthalmic Institute S.C. (1)  ·  Tun Hussein Onn National Eye Hospital (1)  ·  University of Catanzaro (1)

Countries

Italy (3)  ·  Austria (2)  ·  Greece (2)  ·  United Kingdom (2)  ·  United States (2)  ·  Belgium (1)  ·  France (1)  ·  Germany (1)  ·  Malaysia (1)  ·  Poland (1)  ·  Spain (1)  ·  Switzerland (1)  ·  Venezuela (1)

Top investigators

Christophe Baudouin, Professor (1)  ·  Gus Gazzard, MA FRCOphth (1)  ·  Hsien Han Lim (1)  ·  John Liu, PhD (1)  ·  Luciano Quaranta, MD (1)  ·  Luigi Varano, M. D. (1)  ·  Thomas E. Bournias, MD (1)  ·  Vanessa Vera, MD (1)

Results publications

PMID 19157559, PMID 20553122, PMID 23681371, PMID 29267575, PMID 30758653